Galanin receptor over-expression within the amygdala in early Alzheimer's disease:: An in vitro autoradiographic analysis

Sylvia Pérez, Margret Basile, Deborah C Mash, Elliott J. Mufson

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Galanin receptor (GALR) expression is increased in various areas of the limbic system in end stage Alzheimer's disease (AD). The amygdaloid complex is a key component of the limbic circuit, is involved in homeostatic and cognitive functions, is impacted in AD and contains the peptide and receptor for galanin. Although GALR expression occurs in the amygdala in end stage AD, it remains to be determined whether a plasticity response occurs early or late in the disease. Therefore, we analyzed the distribution and associated changes in GALR binding in the amygdala during the progression of AD using an in vitro receptor autoradiographic method. Human galanin ([125I]hGAL) receptor binding was performed on brain sections from early and late AD cases, as well as normal age-matched control subjects. In aged controls, densities of [125I]hGAL binding sites were found in the central and the corticomedial nuclei. Relative to controls, possible/early AD cases displayed significantly greater numbers of [125I]hGAL binding sites in the central nucleus and cortico-amygdaloid transition area. In contrast, we found a decrease in the number of binding sites for [125I]hGAL in late as compared to early AD cases. The over-expression of GALRs in subfields of the amygdaloid early in AD suggests that galaninergic systems play a key role in limbic related behavioral changes during the disease process.

Original languageEnglish
Pages (from-to)109-116
Number of pages8
JournalJournal of Chemical Neuroanatomy
Volume24
Issue number2
DOIs
StatePublished - Jul 1 2002

Fingerprint

Galanin Receptors
Amygdala
Alzheimer Disease
Galanin
Binding Sites
Limbic System
Peptide Receptors
In Vitro Techniques
Cognition

Keywords

  • Aging
  • Amygdaloid
  • Brain
  • Cortex
  • Galaninergic
  • Neuropathology
  • Plasticity

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Galanin receptor over-expression within the amygdala in early Alzheimer's disease:: An in vitro autoradiographic analysis. / Pérez, Sylvia; Basile, Margret; Mash, Deborah C; Mufson, Elliott J.

In: Journal of Chemical Neuroanatomy, Vol. 24, No. 2, 01.07.2002, p. 109-116.

Research output: Contribution to journalArticle

Pérez, Sylvia ; Basile, Margret ; Mash, Deborah C ; Mufson, Elliott J. / Galanin receptor over-expression within the amygdala in early Alzheimer's disease:: An in vitro autoradiographic analysis. In: Journal of Chemical Neuroanatomy. 2002 ; Vol. 24, No. 2. pp. 109-116.
@article{ed63a074c0c24748a02c636f752e08d4,
title = "Galanin receptor over-expression within the amygdala in early Alzheimer's disease:: An in vitro autoradiographic analysis",
abstract = "Galanin receptor (GALR) expression is increased in various areas of the limbic system in end stage Alzheimer's disease (AD). The amygdaloid complex is a key component of the limbic circuit, is involved in homeostatic and cognitive functions, is impacted in AD and contains the peptide and receptor for galanin. Although GALR expression occurs in the amygdala in end stage AD, it remains to be determined whether a plasticity response occurs early or late in the disease. Therefore, we analyzed the distribution and associated changes in GALR binding in the amygdala during the progression of AD using an in vitro receptor autoradiographic method. Human galanin ([125I]hGAL) receptor binding was performed on brain sections from early and late AD cases, as well as normal age-matched control subjects. In aged controls, densities of [125I]hGAL binding sites were found in the central and the corticomedial nuclei. Relative to controls, possible/early AD cases displayed significantly greater numbers of [125I]hGAL binding sites in the central nucleus and cortico-amygdaloid transition area. In contrast, we found a decrease in the number of binding sites for [125I]hGAL in late as compared to early AD cases. The over-expression of GALRs in subfields of the amygdaloid early in AD suggests that galaninergic systems play a key role in limbic related behavioral changes during the disease process.",
keywords = "Aging, Amygdaloid, Brain, Cortex, Galaninergic, Neuropathology, Plasticity",
author = "Sylvia P{\'e}rez and Margret Basile and Mash, {Deborah C} and Mufson, {Elliott J.}",
year = "2002",
month = "7",
day = "1",
doi = "10.1016/S0891-0618(02)00034-0",
language = "English",
volume = "24",
pages = "109--116",
journal = "Journal of Chemical Neuroanatomy",
issn = "0891-0618",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Galanin receptor over-expression within the amygdala in early Alzheimer's disease:: An in vitro autoradiographic analysis

AU - Pérez, Sylvia

AU - Basile, Margret

AU - Mash, Deborah C

AU - Mufson, Elliott J.

PY - 2002/7/1

Y1 - 2002/7/1

N2 - Galanin receptor (GALR) expression is increased in various areas of the limbic system in end stage Alzheimer's disease (AD). The amygdaloid complex is a key component of the limbic circuit, is involved in homeostatic and cognitive functions, is impacted in AD and contains the peptide and receptor for galanin. Although GALR expression occurs in the amygdala in end stage AD, it remains to be determined whether a plasticity response occurs early or late in the disease. Therefore, we analyzed the distribution and associated changes in GALR binding in the amygdala during the progression of AD using an in vitro receptor autoradiographic method. Human galanin ([125I]hGAL) receptor binding was performed on brain sections from early and late AD cases, as well as normal age-matched control subjects. In aged controls, densities of [125I]hGAL binding sites were found in the central and the corticomedial nuclei. Relative to controls, possible/early AD cases displayed significantly greater numbers of [125I]hGAL binding sites in the central nucleus and cortico-amygdaloid transition area. In contrast, we found a decrease in the number of binding sites for [125I]hGAL in late as compared to early AD cases. The over-expression of GALRs in subfields of the amygdaloid early in AD suggests that galaninergic systems play a key role in limbic related behavioral changes during the disease process.

AB - Galanin receptor (GALR) expression is increased in various areas of the limbic system in end stage Alzheimer's disease (AD). The amygdaloid complex is a key component of the limbic circuit, is involved in homeostatic and cognitive functions, is impacted in AD and contains the peptide and receptor for galanin. Although GALR expression occurs in the amygdala in end stage AD, it remains to be determined whether a plasticity response occurs early or late in the disease. Therefore, we analyzed the distribution and associated changes in GALR binding in the amygdala during the progression of AD using an in vitro receptor autoradiographic method. Human galanin ([125I]hGAL) receptor binding was performed on brain sections from early and late AD cases, as well as normal age-matched control subjects. In aged controls, densities of [125I]hGAL binding sites were found in the central and the corticomedial nuclei. Relative to controls, possible/early AD cases displayed significantly greater numbers of [125I]hGAL binding sites in the central nucleus and cortico-amygdaloid transition area. In contrast, we found a decrease in the number of binding sites for [125I]hGAL in late as compared to early AD cases. The over-expression of GALRs in subfields of the amygdaloid early in AD suggests that galaninergic systems play a key role in limbic related behavioral changes during the disease process.

KW - Aging

KW - Amygdaloid

KW - Brain

KW - Cortex

KW - Galaninergic

KW - Neuropathology

KW - Plasticity

UR - http://www.scopus.com/inward/record.url?scp=0036630343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036630343&partnerID=8YFLogxK

U2 - 10.1016/S0891-0618(02)00034-0

DO - 10.1016/S0891-0618(02)00034-0

M3 - Article

C2 - 12191727

AN - SCOPUS:0036630343

VL - 24

SP - 109

EP - 116

JO - Journal of Chemical Neuroanatomy

JF - Journal of Chemical Neuroanatomy

SN - 0891-0618

IS - 2

ER -